Skip to content

Oscillating Positive Expiratory Pressure (OPEP) Therapy in Trauma Patients With Multiple Rib Fractures

Oscillating Positive Expiratory Pressure (OPEP) Therapy in Trauma Patients With Multiple Rib Fractures: A Randomized Comparative Trial Against Incentive Spirometry

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04100512
Enrollment
50
Registered
2019-09-24
Start date
2019-10-21
Completion date
2023-10-31
Last updated
2022-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Complication, Rib Fractures

Brief summary

To determine the efficacy of oscillatory positive expiratory pressure (OPEP) therapy on patients admitted through the trauma service line for rib fractures, as compared to incentive spirometry (IS).

Detailed description

Patients identified through screening procedures to fit the inclusion criteria will be approached, within 48 hours of floor admission, to participate in the study. Once written informed consent is obtained, participants will be randomized, in a 1:1 ratio, into either the IS or OPEP study group. Each patient will be instructed on how to use the respiratory therapy device, either IS or OPEP, by research personnel and respiratory therapists. Participants will be instructed to record their compliance with the RT protocol in their respective patient diaries. Respiratory Therapy will record FVC three times daily on all study participants until stable (FVC \> 1.5L x 4), then daily for up to 7 days or until discharge. Participants will be contacted on day 30 from discharge, and administered a short questionnaire. All participants will be followed and monitored per standard of care, under the care and supervision of their treating provider teams.

Interventions

Aerobika® Oscillating Positive Expiratory Pressure (OPEP) device is a drug-free, easy to use, hand-held device with a proprietary pressure-oscillation dynamic that provides intermittent resistance and creates positive pressure and oscillations simultaneously. The Aerobika® OPEP device opens weak or collapsed airways to mobilize and assist mucociliary clearance to the upper airways where it can be coughed out.

DEVICEIncentive spirometry

An incentive spirometer is a device that measures how deeply you can inhale (breathe in). It helps you take slow, deep breaths to expand and fill your lungs with air. The incentive spirometer is made up of a breathing tube, an air chamber, and an indicator.

Sponsors

Monaghan Medical Corporation
CollaboratorUNKNOWN
Poudre Valley Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Greater than or equal to 18 years old * Greater than or equal to 1 Rib Fracture * Admitted to trauma services at Medical Center of the Rockies (MCR).

Exclusion criteria

* Less than 18 years old * Any physical injury that creates inability to functionally use devices * Adults unable to consent or cooperate due to * Dementia * Confusion * On ventilator support * Moderate to severe Traumatic brain injury (Glasgow Coma Scale \< 12) * Cervical spinal cord injury * Women who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Time (hours) to stable forced vital capacity3 times daily, until FVC is >1.5 liters x 4 consecutive tests, or up to 4 weeksTime (hours) to stable forced vital capacity (FVC) defined as \>1.5 liters x 4 tests and FVC at 7 days for both IS and OPEP participants.

Countries

United States

Contacts

Primary ContactJulie Dunn, MD
julie.dunn@uchealth.org970.624.1689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026